Subscribe to RSS
DOI: 10.1055/s-0043-125034
Eine für Alle – Alle für Eine(n)?
Über öffentliche Impfempfehlungen, den medizinischen Standard und die HerdenimmunitätPublication History
Publication Date:
16 April 2018 (online)
Zusammenfassung
Den Impfempfehlungen der Ständigen Impfkommission (STIKO) kommt in der öffentlichen Diskussion in Deutschland zunehmend die Qualität eines Pflichtkatalogs zu, dessen verpflichtender Charakter vor allem mit dem Argument der durch flächendeckende Impfungen angenommenen Herdenimmunität begründet wird.
In dieser Arbeit wird nachgewiesen, dass es bei Impfempfehlungen keinen medizinischen Standard oder Konsens gibt und dass für die meisten empfohlenen Impfungen keine relevante Herdenimmunität angenommen werden kann.
Summary
The recommendations for immunization in Germany by the STIKO are increasingly interpreted as a mandatory catalogue all the more considering the supposedly implicit herd immunity induced by vaccination.
In this paper it is demonstrated that concerning immunization there is no medical standard or consensus and that for the majority of the recommended vaccinations no relevant herd immunity can be assumed.
-
Literatur
- 1 ABIM Foundation. Choosing wisely: Promoting conversations between providers and patients. Choosing wisely. Im Internet: www.choosingwisely.org; Stand: 06.01.2018
- 2 Althouse BM. Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicine 2015 13. Im Internet: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0382-8; Stand: 06.01.2018
- 3 Anderson RM. May RM. Vaccination against rubella and measles: Quantitative investigations of different policies. J Hyg Camb 1983; 90: 259-325
- 4 Ärztliches Zentrum für Qualität in der Medizin. Surrogatendpunkt — ÄZQ. Leitlinien.de 2016 Im Internet: www.leitlinien.de/glossar/surrogatendpunkt; Stand: 06.01.2018
- 5 Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerging infectious diseases 1996; 2: 176
- 6 Baxter R. Bartlett J. Fireman B. et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics 2017; 139: e20164091
- 7 2 BGH. AZ VI ZR 48_99 – Urteil vom 15. 02.2000. Im Internet: http://juris.bundesgerichtshof.de/cgi-bin/rechtsprechung/document.py?Gericht=bgh&Art=en&nr=23581&pos=0&anz=1; Stand: 06.01.2018
- 8 Castagnini LA. Healy CM. Rench MA. et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clinical Infectious Diseases 2012; 54: 78-84
- 9 CDU. Sonstige Beschlüsse – 28. Parteitag der CDU Deutschlands 2015. Im Internet: www.cdu.de/system/tdf/media/dokumente/sonstige-beschluesse.pdf?file=1; Stand: 06.01.2018
- 10 Centers for Disease Control and Prevention. Update mumps outbreak – New York and New Jersey, June 2009–January 2010. MMWR Morbidity and Mortality Weekly Report 2010; 59. 125-129
- 11 Centers for Disease Control and Prevention. Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine – Illinois, 2015–2016. MMWR Morbidity and Mortality Weekly Report 2016; 65: 731-734
- 12 Centers for Disease Control and Prevention. Pertussis | Whooping Cough | Frequently Asked Questions | CDC. CDC 2017 Im Internet: www.cdc.gov/pertussis/about/faqs.html; Stand: 06.01.2018
- 13 Dayan GH. Quinlisk MP. Parker AA. et al. Recent resurgence of mumps in the United States. New England Journal of Medicine 2008; 358: 1580-1589
- 14 De Serres G. Gay NJ. Farrington CP. Epidemiology of transmissible diseases after elimination. American Journal of Epidemiology 2000; 151: 1039-1048
- 15 Durrheim DN. Crowcroft NS. Strebel PM. Measles – The epidemiology of elimination. Vaccine 2014; 32: 6880-6883
- 16 ECDC. Varicella Vaccination in the European Union. Stockholm; 2015
- 17 ECDC. Annual Epidemiological Report 2016: Invasive Haemophilus influenzae Disease. Stockholm; 2016
- 18 ECDC. Surveillance Atlas of Infectious Diseases. Surveillance Atlas of Infectious Diseases. Im Internet: http://atlas.ecdc.europa.eu/public/index.aspx; Stand: 06.01.2018
- 19 Edmunds WJ. Gay NJ. Kretzschmar M. et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiology & Infection 2000; 125: 635-650
- 20 Eurostat. Kinder- und Jugendbevölkerung am 1. Januar nach Geschlecht und Alter. Eurostat. Im Internet: http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=yth_demo_010&lang=de; Stand: 06.01.2018
- 21 Ewald H. Briel M. Vuichard D. et al. Klinische Wirksamkeit von Pneumokokken-Konjugatimpfstoffen. Dtsch Arztebl International 2016; 113: 139-146
- 22 FDP. BESCHLUSS des 68. Ord. Bundesparteitags der FDP, Berlin, 28. bis 30 April 2017 – Kindeswohl schützen – Recht auf Impfung für alle Kinder 2017; Im Internet: www.fdp.de/sites/default/files/uploads/2017/05/08/2017-04-29-bpt-kindeswohl-schuetzen-recht-auf-impfung-fuer-alle-kinder.pdf; Stand: 06.01.2018
- 23 Fine PE. Herd immunity: History, theory, practice. Epidemiologic Reviews 1993; 15: 265-302
- 24 Fine P, Eames K, Heymann DL. „Herd Immunity“: A rough guide. Clinical Infectious Diseases 2011; 52: 911-916
- 25 Fox JP. Elveback L. Scott W. et al. Herd immunity: Basic concept and relevance to public health immunization practices. American Journal of Epidemiology 1971; 94: 179-189
- 26 Fox JP. Herd immunity and measles. Review of Infectious Diseases 1983; 5: 463-466
- 27 Gelderblom H. Die Ausrottung der Pocken. Spektrum.de 1996 Im Internet: www.spektrum.de/magazin/die-ausrottung-der-pocken/823065; Stand: 06.01.2018
- 28 Gesundheitsberichterstattung des Bundes. Sterbefälle Sterbeziffern. Gesundheitsberichterstattung des Bundes. Im Internet: www.gbe-bund.de; Stand: 06.01.2018
- 29 Glatman-Freedman A. Nichols K. The effect of social determinants on immunization programs. Human Vaccines & Immunotherapeutics 2012; 8: 293-301
- 30 Healy CM. Rench MA. Wootton SH. Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. The Pediatric Infectious Disease Journal 2015; 34: 22-26 Im Internet: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP: landingpage&an=00006454-201501000-00006; Stand: 06.01.2018
- 31 Hengel H. von Kries R. Impfen. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2009; 52: 1003-1005
- 32 Hirose M. Gilio AE. Ferronato AE. Ragazzi SLB. The impact of varicella vaccination on varicella-related hospitalization rates: Global data review. Revista Paulista de Pediatria (English Edition) 2016; 34: 359-366
- 33 Horn J. Karch A. Damm O. et al. Current and future effects of varicella and herpes zoster vaccination in Germany: Insights from a mathematical model in a country with universal varicella vaccination. Human Vaccines & Immunotherapeutics 2016; 1-11
- 34 Ishiwada N. Addae MM. Tetteh JKA. et al. Vaccine-modified measles in previously immunized children in Accra, Ghana clinical, virological and serological parameters.pdf. Tropical Medicine and International Health 2001; 6: 694-698
- 35 Jónsdóttir. Immunisation of infants in Iceland against Haemophilus influenzae type b. The Lancet 1992; 340: 252-253
- 36 Klinge J. Lugauer S. Korn K. et al. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine 2000; 18: 3134-3140
- 37 Ladhani SN. Ramsay ME. Editorial commentary: The story of sisyphus: Why we need a universal pneumococcal vaccine to replace current conjugate vaccines. Clin Infect Dis 2015; 61: 776-778
- 38 Lalwani S. Chatterjee S. Balasubramanian S. et al. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: A phase III, randomised, non-inferiority trial. BMJ open 2015; 5: e007202
- 39 Loo JD. Conklin L. Fleming-Dutra KE. et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. The Pediatric Infectious Disease Journal 2014; 33: S161-S171
- 40 Nardone A. de Ory F. Carton M. et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007 25. Im Internet: Stand: 06.01.2018
- 41 Nardone A. Tischer A. Andrews N. et al. Comparison of rubella seroepidemiology in 17 countries: Progress towards international disease control targets. Bulletin of the World Health Organization 2008; 86: 118-125
- 42 Olarte L. Barson WJ. Barson RM. et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clinical Infectious Diseases 2015; 61: 767-775
- 43 Orenstein WA. Bernier RH. Dondero TJ. et al. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization 1985; 63: 1055
- 44 Pappenheimer AMJ. Diphtheria. In: Germanier R, Hrsg. Bacterial vaccines. Berne; 1984: 1-36
- 45 Peltola H. Virtanen M. Systemic Haemophilus influenzae infection in Finland. Clinical Pediatrics 1984; 23: 275-280
- 46 Peltola H. Rød TO. Jónsdóttir K. et al. Life-threatening Haemophilus influenzae infections in Scandinavia: A five-country analysis of the incidence and the main clinical and bacteriologic characteristics. Reviews of Infectious Diseases 1990; 12: 708-715
- 47 Peltola H. Aavitsland P. Hansen KG. et al. Perspective: A five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. The Journal of Infectious Diseases 1999; 179: 223-229
- 48 Puig C. Grau I. Marti S. et al. Clinical and molecular epidemiology of haemophilus influenzae causing invasive disease in adult patients. PLoS ONE 2014; 9: e112711
- 49 Quinlisk MP. Mumps control today. The Journal of Infectious Diseases 2010; 202: 655-656
- 50 Rabe S. Diphtheriefälle in Deutschland 2009–2015. Impf-Info 2017 Im Internet: www.impf-info.de/images/Med/Diphtherie_D_ab_2009.png; Stand: 06.01.2018
- 51 Rabe S. Impfempfehlungen in Europa. Impf-Info 2017 Im Internet: www.impf-info.de/pdfs/Impfempfehlungen_Westeuropa_2017.pdf; Stand: 06.01.2018
- 52 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Diphtherie. Robert Koch Institut 2009 Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Diphtherie.html; Stand: 06.01.2018
- 53 Robert Koch-Institut. Diphtherie: Erkrankung durch toxigene Corynebacterium ulcerans nach Katzenkontakt – Fallbericht. Epidemiologisches Bulletin 2011; 2011: 245-248
- 54 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Mumps. Robert Koch Institut 2013 Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Mumps.html; Stand: 06.01.2018
- 55 Robert Koch-Institut. Ergebnisse der Modellierung langfristiger epidemiologischer Auswirkungen der Varizellenimpfung in Deutschland. Epidemiologisches Bulletin 2016; 2016: 167-169
- 56 Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2015. Berlin; 2016
- 57 Robert Koch-Institut. Invasive Meningokokken-Erkrankungen 2012–2015. Epidemiologisches Bulletin 2016; 2016: 471-484
- 58 Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut – 2017/2018. Epidemiologisches Bulletin 2017; 2017: 333-374
- 59 Robert Koch-Institut. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2015. Epidemiologisches Bulletin 2017; 2017: 137-142
- 60 Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2016. Berlin; 2017
- 61 Robert Koch-Institut. RKI – Impfungen A–Z: Schutzimpfung gegen Poliomyelitis: Häufig gestellte Fragen und Antworten. Robert Koch Institut 2017. Im Internet: www.rki.de/SharedDocs/FAQ/Impfen/Poliomyelitis/FAQ-Liste_Poliomyelitis_Impfen.html; Stand: 06.01.2018
- 62 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Windpocken, Herpes zoster (Gürtelrose). Robert Koch Institut 2017. Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Varizellen.html; Stand: 06.01.2018
- 63 Robert Koch-Institut. RKI – Ständige Impfkommission. Robert Koch Institut 2017 Im Internet: www.rki.de/DE/Content/Kommissionen/STIKO/stiko_node.html; Stand: 06.01.2018
- 64 Rosen JB. Rota JS. Hickman CJ. et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clinical Infectious Diseases 2014; 58: 1205-1210
- 65 Saragea A. Maximescu P. Meitert E. Corynebacterium diphtheriae: Microbiological methods used in clinical and epidemiological investigations. In: Bergam T, Norris FR, eds. Methods in Microbiology. New York; 1979: 61-176
- 66 Schmitz R, Poethko-Muller C, Reiter S, Schlaud M. Impfstatus und Gesundheit von Kindern und Jugendlichen. Deutsches Ärzteblatt International 2011; 108: 99-104
- 67 Smith PG. Concepts of herd protection and immunity. Procedia in Vaccinology 2010; 2: 134-139
- 68 Statens Serum Institut. Theme on temporary change of the childhood vaccination program – Statens Serum Institut. Statens Serum Institut 2016. Im Internet: https://www.ssi.dk/English/News/EPI-NEWS/2016/No%203%20-%202016.aspx; Stand: 06.01.2018
- 69 Strebel PM. Gacic-Dobo M. Reef S. Cochi SL. Global use of rubella vaccines, 1980–2009. The Journal of Infectious Diseases 2011; 204: S579-S584
- 70 Strebel PM. Measles vaccines. In: Plotkin SA, Orenstein WA, Offit W, eds. Plotkin’s Vaccines. Philadelphia; Elsevier: 2018
- 71 Streng A. Grote V. Carr D. et al. Varicella routine vaccination and the effects on varicella epidemiology–results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infectious Diseases 2013; 13: 303
- 72 Takala AK. Eskola J. Leinonen M. et al. Reduction of oropharyngeal carriage of haemophilus influenzae Type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991; 164: 982-986
- 73 Trotter CL. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. American Journal of Epidemiology 2005; 162: 89-100
- 74 Trotter CL. Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Review of Vaccines 2009; 8: 851-861
- 75 Uzicanin A. Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: A review of published literature. The Journal of Infectious Diseases 2011; 204: S133-S149
- 76 Waight PA. Andrews NJ. Ladhani SN. et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study. The Lancet Infectious Diseases 2015; 15: 535-543
- 77 Warfel JM. Zimmerman LI. Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proceedings of the National Academy of Sciences 2014; 111: 787-792
- 78 Weinberger DM. Malley R. Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. The Lancet 2011; 378: 1962-1973
- 79 Whittaker R. Economopoulou A. Dias JG. et al. Epidemiology of invasive Haemophilus influenzae Disease, Europe, 2007–2014. Emerging Infectious Diseases 2017; 23: 396-404
- 80 WHO. Pertussis vaccines: WHO position paper. Weekly Epidemiological Record 2010; 85: 385-400
- 81 WHO. Background Paper on Varicella Vaccine – SAGE Working Group on Varicella and Herpes Zoster Vaccines. 2014 Im Internet: www.who.int/immunization/sage/meetings/2014/april/1_SAGE_varicella_background_paper_FINAL.pdf?ua=1; Stand: 06.01.2018
- 82 WHO. Varicella and herpes zoster vaccines WHO position paper, June 2014. Weekly Epidemiological Record 2014; 89: 265-288
- 83 WHO. WHO SAGE pertussis working group Background paper SAGE April 2014 Im Internet: www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf; Stand: 06.01.2018
- 84 WHO. Measles vaccines: WHO position paper. Weekly Epidemiological Record 2017; 92: 205-227
- 85 WHO. WHO | WHO recommendations for routine immunization – summary tables. Im Internet: www.who.int/immunization/policy/immunization_tables/en/; Stand: 06.01.2018
- 86 Wiedermann U. Unterschiedliche Impfschemata in Europa: Führen alle Wege nach Rom?. Monatsschrift Kinderheilkunde 2009; 157: 743-750
- 87 Zensusdatenbank Zensus. 2011 Zensusdatenbank – Ergebnisse dynamisch und individuell. Zensus2011. Im Internet: https://ergebnisse.zensus2011.de/#dynTable: statUnit=PERSON;absRel=ANZAHL;ags=00;agsAxis=X;yAxis=ALTER_KURZ:1;table; Stand: 06.01.2018